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Wild-type p53 (wt p53) has multi-functions, including suppression
of cancer initiation and tumour growth through the induction of
downstream genes and/or protein interaction (Caelles et al, 1994;
Dulic et al, 1994; El-Deiry et al, 1994; Waga et al, 1994). In a
recent clinical report, we showed that wtp53 patients show higher
survival rate after radiotherapy, resulting from Bax and Bcl-2 regu-
lation, compared with mutated p 53 (mp53) patients (Harima et al,
1998). To trigger the multi-functions of p53, p53 is required to form
the correct conformation which enables p53 to bind to specific
DNA sequences regulating gene expression. Mutations in the p53
gene cause conformational alterations in the p53 protein, and the
majority of mp53 proteins can no longer regulate expression of
downstream genes (Bargonetti et al, 1991; Kern et al, 1991). Mp53
genes are frequently observed in human cancer cells (Hollstein et
al, 1991; Jia et al, 1997). Thus, a strategy for inducing mp53 to fold
correctly could be useful for cancer therapy. We have recently
reported that heat stress induces WAF1 expression only when p53
protein is wtp53 using a human glioblastoma cell line (A-172,
wtp53) and its transfectants with an mp53 vector (A-172/mp53)
(Ohnishi et al, 1996, 1998). A-172 mp53 cells abolished heat-
induced WAF1 expression due to the dominant negative nature of
the mp53 protein over endogenous wtp53 (Kern et al, 1992; Unger
et al, 1992). However, heat-induced WAF1 accumulation was
restored in these mp53-transfected cells when the cells were pre-
treated with glycerol (Ohnishi et al, 1999a). Glycerol thus appeared
to confer wtp53 function on mp53. The function of glycerol as a
chemical chaperone has been reported elsewhere (Thomas et al,
1995; Welch and Brown, 1996). Glycerol seems to correct the
conformation of some types of proteins which cause human
diseases. 
MATERIALS AND METHODS 
Cells 
Head and neck cell line of human squamous cell carcinoma, SAS
cells (provided by JCRB, Tokyo, Japan) were cultured at 37˚C in
Dulbecco’s Modified Eagle medium containing 10% (v/v) fetal
bovine serum, penicillin (50 U ml–1), streptomycin (50 µ g ml–1)
and kanamycin (50 µ g ml–1) (DMEM-10) in a conventional
humidified 5% CO2 incubator. 
Plasmids 
SAS cells were transfected with plasmid pC53–248, which
contains an mp53 gene (codon 248, from Arg to Trp) which
encodes a dominant negative mp53, or with the control vector
pCMV-Neo-Bam. These plasmids were provided by B Vogelstein, 
Johns Hopkins Oncology Center, MD, USA. The stable transfect-
ants SAS/mp53 and SAS/neo were selected with G418 (200–
400 µ g ml–1, Sigma Chemical Co, St Louis, MO), and used for the
present experiments. Detailed procedure for transfection is
described elsewhere (Ohnishi et al, 1998). 
Glycerol treatment 
Cells were treated with glycerol (at final concentration of 0.6 M)
48 h before X-ray irradiation and then were incubated at 37˚C for
10 h in the presence of glycerol until sampling. X-ray irradiation
was performed in the presence of glycerol. In the case of cell
survival assay, the medium with glycerol was changed with
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cells were incubated for 10 to 14 days at 37˚C in glycerol-free
medium. 
X-ray irradiation 
For the X-ray irradiation treatment, subconfluent cells in 25-cm2
flasks containing DMEM-10 were exposed to X-rays (2.5–10 Gy)
using a 150 kVp X-ray generator (Model MBR-1520R, Hitachi,
Tokyo, Japan) with a total filtration of 0.5 mm aluminium plus 
0.1 mm copper filter, and then incubated at 37˚C. 
Cell survival assay 
To measure radiosensitivity of the cells, cell survival after X-ray
irradiation was quantitated by plating cells into 25 cm2 flask
containing the medium. Thereafter, cell colonies were rinsed with
PBS, fixed with methanol, stained with 2% Giemsa solution
(Merck, Woodbridge, NJ, USA). Colonies containing at least 50
cells were counted. The number of cells per colony was deter-
mined prior to experiments. 
Analysis of apoptosis 
Induction of apoptosis was analysed by detection of both DNA
fragmentation and apoptotic bodies. To detect DNA fragmentation
in the nucleosomal size range, cells were suspended in lysis buffer
containing 10 mM Tris-HCl, pH 7.4, 10 mM NaCl, 10 mM EDTA
and 1% sodium N-lauroylsarcosinate, incubated with 100 µ g ml–1
proteinase K at 37˚C overnight, and then centrifuged at 18500 g
for 30 min. The resulting supernatants were incubated with
100 µ g ml–1 RNase A at 37˚C for 1 h. The DNA in the solution was
precipitated with ethanol at –20˚C, dissolved in 10 mM Tris-HCl,
pH 8.0, and 1 mM EDTA, and electrophoresed for 30 min at 100 V
through 3% NuSieve 3:1 gels containing 40 mM Tris-acetate,
pH 7.8, 2 mM EDTA and 0.5 µ g ml–1 ethidium bromide. After
electrophoresis, the gels were photographed under ultraviolet
light. For detection of apoptotic bodies, cells were fixed with 
1% glutaraldehyde (Nakalai Tesque, Kyoto, Japan) in PBS 
at 4˚C, washed with PBS, stained with 0.2 mM Hoechst 
33342 (Sigma Chemical Co), and then observed under a
fluorescence microscope. At least 300 cells were counted in each
experiment. 
Gel mobility-shift assay 
In in vivo samples, the cells (about 2 × 107 cells) were irradiated
with X-rays (6 Gy) in the presence or absence of glycerol (0.6 M).
The nuclear extracts were prepared 6 h after X-ray irradiation
according to the method described elsewhere (Ohnishi et al, 1998).
In in vitro samples, whole cell extracts were prepared from intact
cells (about 2 × 107 cells) and treated with glycerol (0.6 M), X-rays
(6 Gy) or a combination of glycerol and X-rays (6 Gy), and subse-
quently incubated for 30 min at 37˚C. The p53–p53 consensus
sequence (p53CON) binding activity was measured by a gel
mobility-shift assay (Ohnishi et al, 1998) using a synthetic double-
stranded DNA fragment encoding the p53CON (5′ -GGACATGC-
CCGGGCATGTCC-3′ , Japan Bioservice, Niiza, Saitama, Japan)
based on a specific sequence located upstream of the bax gene 
as a probe. 
RESULTS AND DISCUSSION 
To examine the effect of glycerol on the radiosensitivity of
SAS/mp53 and SAS/neo cells, the clonogenic surviving fractions
after X-ray irradiation combined with pre-treatment with or
without glycerol (0.6 M) were measured. As shown in Figure 1,
the SAS/mp53 cells were about 1.5 times more resistant to X-rays
than the SAS/neo cells at the D10 dose. However, when pre-treated
with glycerol, SAS/mp53 cells become about 1.5 times more X-
ray-sensitive at the D10 dose. Glycerol caused little enhancement
of X-ray sensitivity in SAS/neo cells. On the other hand,
SAS/mp53 and SAS/neo cells treated with glycerol alone (0.6 M)
showed about 80% surviving fractions, and thus 0.6 M glycerol
appeared to cause no serious cell damage regardless of p53 status.
These results suggest that glycerol affects the radiosensitivity of
these cells in a p53-dependent manner. 
Furthermore, we examined the induction of apoptosis by detec-
tion of apoptotic bodies and DNA fragmentation to elucidate the
mechanism of enhancement of radiosensitivity by glycerol in
SAS/mp53 cells. We analysed the nuclear morphology with
Hoechst 33342 staining. We scored the number of apoptotic bodies
such as those shown by arrows in the insert of Figure 2. The incid-
ence of apoptosis increased with time after X-ray irradiation
(6 Gy) in SAS/neo cells (about 10% at 48 h), while there was
almost no increase in the incidence of apoptosis up to 72 h after
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Figure 1 Clonogenic surviving fractions of transformant SAS cells after 
X-ray irradiation measured by the colony formation assay. Open circles,
SAS/neo cells; closed circles, SAS/neo cells pre-treated with 0.6 M glycerol
for 48 h before X-ray irradiation; open triangles, SAS/mp53 cells; closed
triangles, SAS/mp53 cells pre-treated with 0.6 M glycerol. Surviving fractions
were measured in 3 independent duplicate experimentsX-ray irradiation in SAS/mp53 cells (about 3%). The rate of apop-
tosis in SAS/neo cells was about 5-fold higher than that in
SAS/mp53 cells at 48–72h after X-ray irradiation (Figure 2).
When treated with glycerol (0.6 M) before X-ray irradiation, the
SAS/mp53 cells underwent apoptosis with time after X-ray irradi-
ation (6 Gy). The time course of X-ray-induced apoptosis in the
glycerol-treated SAS/mp53 cells was similar to that in SAS/neo
cells. We next examined the induction of DNA fragmentation after
X-ray irradiation (6 Gy) using agarose gel electrophoresis of DNA
extracted from SAS/neo (Figure 3, lanes 1–5) and SAS/mp53 cells
(Figure 3, lanes 7–11). No DNA ladder formation was detected
after X-ray irradiation alone in SAS/mp53 cells (Figure 3, upper
right panel). However, some DNA ladders in the nucleosomal size
range were observed 24–72 h after X-ray irradiation combined
with glycerol (0.6 M) (Figure 3, lower right panel). In contrast,
SAS/neo showed the DNA ladders after X-ray irradiation in the
absence (Figure 3, upper left panel) or presence (Figure 3, lower
left panel) of 0.6 M glycerol. Glycerol alone induced no apoptotic
bodies or DNA fragmentation in either type of transformed cells
(data not shown). These results showed that the X-ray-induced
apoptosis was p53-dependent. 
To confirm whether glycerol induces mp53 to adapt the con-
formation of wtp53, the DNA binding activity of p53 for p53CON
was measured in nuclear or whole cell proteins extracted from
SAS/neo or SAS/mp53 cells using the gel mobility-shift assay
(Figure 4). Wt p53 is known to bind to p53CON, which is homol-
ogous to a specific DNA sequence located upstream of the bax
gene and which positively controls apoptosis (Miyashita and Reed,
1995). As supporting the evidence, in in vivo samples, DNA
binding activity of nuclear proteins was increased in SAS/neo cells
treated with X-ray (6 Gy) combined with or without 0.6 M glyc-
erol (Figure 4). Mp53 can not enhance apoptosis, because most
mp53 can not bind to the specific DNA sequence. In fact, in in
vivo samples, no DNA binding activity of nuclear proteins was
detected in the intact SAS/mp53 cells (Figure 4, lane 1 of in vivo)
and this activity level was unchanged even when SAS/mp53 cells
were treated with glycerol (0.6 M) or X-rays (6 Gy) (Figure 4,
p53-dependent radiosensitivity and chemical chaperone 1737
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Figure 2 Apoptotic bodies detected with Hoechst 33342 staining. The cells
were incubated at 37˚C for 0, 12, 24, 48 or 72 h after X-ray irradiation (6 Gy)
with or without glycerol (0.6 M), fixed with glutaraldehyde, stained with
Hoechst 33342, and then observed under a fluorescence microscope.
Apoptotic bodies were counted under 3 different fields of the microscopic
observation. 100 cells were judged under one field. The symbols are the
same as in Figure 1. Inserted photograph, SAS/mp53 cells 48 h after X-ray
irradiation (6 Gy) with glycerol (0.6 M) treatment. Arrows indicate apoptotic
bodies 
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Figure 3 DNA fragmentation detected by agarose gel electrophoresis of
DNA extracted from SAS/neo (lanes 1–5) and SAS/mp53 cells (lanes 7–11)
after X-ray irradiation (6 Gy) (upper panel) or after X-ray irradiation (6 Gy) in
the presence of 0.6 M glycerol (lower panel). After the incubation at 37˚C for
12, 24, 42, or 72 h, the cells were suspended in the lysis buffer to extract
DNA for gel electrophoresis. Lanes 1 and 7, unirradiated; lanes 2 and 8, at
12 h; lanes 3 and 9, at 24 h; lanes 4 and 10, at 42 h; lanes 5 and 11, at 72 h
after X-ray irradiation. Lane 6, øX174 DNA Hae III fragments as size markers 
p53/p53CON
p53/p53CON SAS/neo
SAS/mp53
X-ray (6 Gy)
Glycerol (0.6M)
in vivo in vitro
Figure 4 DNA binding activity of nuclear or whole cell extracts from
SAS/neo or SAS/mp53 cells for p53CON. In in vivo sample, the cells were
incubated at 37˚C for 6 h after glycerol (0.6 M) treatment or X-ray irradiation
(6 Gy) combined with or without glycerol. After the incubation, the cells were
washed with PBS and harvested for gel mobility-shift assay. In in vitro
sample, whole cell extracts from SAS/neo or SAS/mp53 cells were treated
with glycerol (0.6 M) or X-ray irradiation (6 Gy) combined with or without
glycerol and then incubated for 30 min at 37˚C. The band position of the
specific p53-p53CON complex is shown by arrow lanes 2 and 3 of in vivo). The defective DNA binding ability of
p53 from SAS/mp53 cells may be due to the dominant negative
nature of this mp53 protein (Kern et al, 1992; Unger et al, 1992).
In contrast, when SAS/mp53 cells were treated with glycerol (0.6
M) before X-ray irradiation, nuclear proteins prepared from the
cells showed a clear increase of DNA binding activity, probably
due to binding of p53 to p53CON (Figure 4 lane 4 of in vivo).
When unlabelled p53CON probe (× 100) was added to the reaction
mixture containing 32P-labelled p53CON and the nuclear proteins
from SAS/mp53 cells treated with X-rays combined with glycerol,
the binding of p53 to p53CON disappeared (data not shown). This
indicates that the observed bands are p53-p53CON specific bands.
From these results, the apoptosis observed in SAS/mp53 cells
(Figures 2 and 3) might be induced through bax gene expression
which is up-regulated by the activated mp53, which underwent a
conformational change to wtp53 as reported elsewhere (Brown et
al, 1997). The acquisition of binding activity of glycerol-treated
mp53 is likely to demand cellular signal transduction induced by
X-rays, because no binding activity of p53 was observed when
whole cell proteins extracted from intact SAS/neo or SAS/mp53
cells were treated with X-ray (Figure 4, lane 3 of in vitro) or X-ray
combined with glycerol (Figure 4, lane 4 of in vitro). 
We showed that X-ray or glycerol treatment alone was insuffi-
cient to convert the conformation of mp53 to that of active wtp53,
because neither treatment led to an increase in the DNA binding
activity of p53 (Figure 4). Therefore, we assume that conforma-
tional change of mp53 to that of wtp53 induced by glycerol is not
sufficient to trigger apoptosis, and some initial signals evoked by
X-ray irradiation are required for effective signals leading to apop-
tosis. Conformation-stabilized p53 produced by glycerol treatment
is probably activated through phosphorylation by X-ray-activated
protein kinases such as ATM (Banin et al, 1998; Canman et al,
1998; Khanna et al, 1998; Nakagawa et al, 1999), ATR (Tibbetts 
et al, 1999), PKC (Takenaka et al, 1995) or other kinases (Hall 
et al, 1996, Jamal and Ziff, 1995). The present results suggest 
at least that the apoptosis induced by X-rays reported here depends
on p53-dependent signal transduction. Glycerol may be generally
effective against p53-regulated downstream genes through the
restoration of the function of mp53, because restoration of mp53
function to normal by glycerol is observed in WAF1 induction as
well (Ohnishi et al, 1999a). 
Possible other explanations can be proposed for the increased
DNA binding activity of nuclear extracts from SAS/mp53 cells
after combined X-ray and glycerol treatments. Overexpressed
mp53 may obtain the ability to enhance the DNA binding activity
of endogenous wtp53 due to reactions triggered by the combined
treatments. Unknown signal transduction pathways may
contribute to the modification of mp53 function. 
Some investigators have vigorously searched for molecules
which have an ability to induce normal function of p53 in inactive
p53 or mp53. The latent sequence-specific DNA-binding function
is activated by small peptides (Hupp et al, 1995). As already
described, glycerol induces conformational change of mp53 to
wtp53 (Brown et al, 1997) and restores the ability of mp53 to in-
duce WAF1 expression (Ohnishi, 1999a,b). Similar chaperone-like
function has been also found in other molecules such as a synthetic
peptide derived from p53 C-terminal domain (Selivanova 
et al, 1997) and a small compound (Foster et al, 1999). Such
manipulation of mp53 or inactive p53 by these molecules may
provide new cancer therapies effective for patients carrying mp53
tumours. 
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